Synergic effect of photodynamic therapy using talaporfin sodium with conventional anticancer chemotherapy for the treatment of bile duct carcinoma

Journal of Surgical Research

Volumn 181, Issue 2, 2013, Pages 234-241

  Nonaka, Yoshikazu ^a   Nanashima, Atsushi ^a   Nonaka, Takashi ^a   Uehara, Masataka ^a   Isomoto, Hajime ^a   Abo, Takafumi ^a   Nagayasu, Takeshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bile duct carcinoma; Photodynamic therapy; Synergic effect; Talaporfin sodium

Indexed keywords

CELL NUCLEUS ANTIGEN; CISPLATIN; EIPLAT; FLUOROURACIL; GEMCITABINE; OXALIPLATIN; TALAPORFIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LABELING INDEX; MALE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR REGRESSION; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BILE DUCT NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; DEOXYCYTIDINE; DRUG SYNERGISM; FLUOROURACIL; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MICE; MICE, INBRED BALB C; ORGANOPLATINUM COMPOUNDS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PROLIFERATING CELL NUCLEAR ANTIGEN; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84876418080     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.06.047     Document Type: Article

References (59)

1. P. Agostinis, K. Berg, and K.A. Cengel Photodynamic therapy of cancer: an update CA Cancer J Clin 61 2011 250
2. F. Berr, M. Wiedmann, and A. Tannapfel Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival Hepatology 31 2000 291
3. H. Witzigmann, F. Berr, and U. Ringel Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection Ann Surg 244 2006 230
4. M.E. Ortner, K. Caca, and F. Berr Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study Gastroenterology 125 2003 1355
5. T. Zoepf, R. Jakobs, J.C. Arnold, D. Apel, and J.F. Riemann Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy Am J Gastroenterol 100 2005 2426
6. T. Zoepf Photodynamic therapy of cholangiocarcinoma HPB (Oxford) 10 2008 161
7. A. Nanashima, H. Yamaguchi, and S. Shibasaki Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study J Gastroenterol 39 2004 1095
8. A. Nanashima, H. Yamaguchi, and S. Shibazaki Three cases of hilar cholangiocarcinoma who underwent photodynamic therapy (PDT). The first report J Biliary Tract Pancreas 23 2002 129
9. H. Sato, T. Takada, and M. Miyazaki Radiation therapy and photodynamic therapy for biliary tract and ampullary carcinomas J Hepatobiliary Pancreat Surgery 15 2008 63
10. C.J. Gomer, N. Rucker, A. Ferrario, and S. Wong Properties and applications of photodynamic therapy Radiat Res 120 1989 1
11. J. Usuda, H. Kata, and T. Okunaka Photodynamic therapy for lung cancer J Thorac Oncol 1 2006 489
12. H. Kato, K. Furukawa, and M. Sato Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung Lung Cancer 42 2003 103
13. H. Zheng A review of progress in clinical photodynamic therapy Technol Cancer Res Treat 4 2005 283
14. W.G. Roberts, F.Y. Shiau, J.S. Nelson, K.M. Smith, and M.W. Berns In vitro characterization of monoaspartyl chlorin e6 and diaspartyl chlorin e6 for photodynamic therapy J Natl Cancer Inst 80 1988 330
15. A. Ferrario, D. Kessel, and C.J. Gomer Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model Cancer Res 52 1992 2890
16. W.G. Roberts, K.M. Smith, J.L. McCullough, and M.W. Berns Skin photosensitivity and photodestruction of several potential photodynamic sensitizers Photochem Photobiol 49 1989 431
17. T. Nonaka, A. Nanashima, and M. Nonaka Analysis of apoptotic effects induced by photodynamic therapy in a human biliary cancer cell line Anticancer Res 30 2010 2113
18. T. Nonaka, A. Nanashima, and M. Nonaka Advantages of laserphyrin compared with photofrin in photodynamic therapy for bile duct carcinoma J Hepatobiliary Pancreat Sci 18 2011 592
19. S.R. Alberts, G.J. Gores, and G.P. Kim Treatment options for hepatobiliary and pancreatic cancer Mayo Clin Proc 82 2007 628
20. S. Kubicka, K.L. Rudolph, M.K. Tietze, M. Lorenz, and M. Manns Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas Hepatogastroenterology 48 2001 783
21. M.A. Lee, I.S. Woo, J.H. Kang, Y.S. Hong, and K.S. Lee Gemcitabine and cisplatin combination chemotherapy in intrahepatic cholangiocarcinoma as second-line treatment Jpn J Clin Oncol 34 2004 547
22. J. Valle, H. Wasan, and D.H. Palmer Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer N Engl J Med 362 2010 1273
23. T. Andre, C. Tournigand, and O. Rosmorduc Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study Eur Soc Med Oncol 15 2004 1339
24. B. Blechacz, and G.J. Gores Cholangiocarcinoma Clin Liver Dis 12 2008 131
25. N.L. Oleinick, R.L. Morris, and I. Belichenko The role of apoptosis in response to photodynamic therapy: what, where, why, and how Photochem Photobiol Sci 1 2002 1
26. Y. Luo, C.K. Chang, and D. Kessel Rapid initiation of apoptosis by photodynamic therapy Photochem Photobiol 63 1996 528
27. H.S. Won, M.A. Lee, and E.S. Chung Comparison of thymidine phosphorylase expression and prognostic factors in gallbladder and bile duct cancer BMC Cancer 10 2010 564
28. A.F. Hezel, and A.X. Zhu Systemic therapy for biliary tract cancers Oncologist 13 2008 415
29. A.D. Wagner, P.B. Steudel, and M. Moehler Gemcitabine, oxaliplatin and 5-fu in advanced bile duct and gallbladder carcinoma: two parallel, multicenter phase II trials Br J Cancer 101 2009 1846
30. J.J. Knox, D. Hedley, and A. Oza Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial J Clin Oncol 23 2005 2332
31. J.S. Park, S.Y. Oh, and S.H. Kim Single-agent gemcitabine in the treatment of advanced biliary tract cancers: a phase II study Jpn J Clin Oncol 35 2005 68
32. Y.S. Hong, J. Lee, and S.C. Lee Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer Cancer Chemother Pharmacol 60 2007 321
33. O. Nehls, H. Oettle, and J.T. Hartmann Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial Br J Cancer 98 2008 309
34. K.J. Williams, J. Picus, and K. Trinkhaus Gemcitabine with carboplatin for advanced biliary tract cancers: a phase II single institution study HPB (Oxford) 12 2010 418
35. Y. Tokunaga, T. Kawasaki, H. Sasaki, S. Matsueda, and T. Saito Hepatic metastasis from bile duct cancer of the ampulla is effectively controlled by multidisciplinary treatment including S-1, gemcitabine and bevacizumab: a case report Oncol Lett 1 2010 481
36. T. Okusaka, H. Ishii, and A. Funakoshi Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer Cancer Chemother Pharmacol 57 2006 647
37. T. Ohshiro, T. Nakajima, H. Ogata, and K. Kishi Histological responses of cutaneous vascular lesions following photodynamic therapy with talaporfin sodium Keio J Med 58 2009 176
38. T. Tomioka, T. Kushibiki, and K. Awazu Evaluation of oxygen consumption of culture medium and in vitro photodynamic effect of talaporfin sodium in lung tumor cells Photomed Laser Surg 28 2010 385
39. C.J. Gomer, A. Ferrario, M. Luna, N. Rucker, and S. Wong Photodynamic therapy: combined modality approaches targeting the tumor microenvironment Lasers Surg Med 38 2006 516
40. T.J. Dougherty An update on photodynamic therapy applications J Clin Laser Med Surg 20 2002 3
41. J. Usuda, T. Okunaka, and K. Furukawa Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosis Int J Cancer 93 2001 475
42. M.S. Ricci, and W.X. Zong Chemotherapeutic approaches for targeting cell death pathways Oncologist 11 2006 342
43. F. Fujita, S. Fujita, M. Fujita, and Y. Sakamoto Antitumor activity of combination treatment combining gemcitabine with cisplatin or vindesine against human lung cancer xenografted in nude mice Cancer Chemother 21 1994 2595
44. R.M. Schultz, R.L. Merriman, J.E. Toth, J.E. Zimmermann, and L.W. Hertel Evaluation of new anticancer agents against the PaCa-2 and PNNC-1 human pancreatic carcinoma xenografts Oncol Res 5 1993 223
45. Q. Xie, C.G. Wei, L. Jia, and Y.H. Liu Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer in vivo World J Gastroenterol 15 2009 737
46. L.W. Hertel, G.B. Boder, and J.S. Kroin Evaluation of the antitumor activity of gemcitabine Cancer Res 50 1990 4417
47. M.B. Mathews, R.M. Bernstein, B.R. Franza Jr., and J.I. Garrels Identity of the proliferating cell nuclear antigen and cyclin Nature 309 1984 374
48. R. Bravo, R. Frank, P.A. Blundell, and H. Macdonald-Bravo Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta Nature 326 1987 515
49. L.M. Wong Kee Song, K.K. Wang, and A.R. Zinsmeister Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model Cancer 82 1998 421
50. W. Kobayashi, Q. Liu, and T. Matsumiya Photodynamic therapy upregulates expression of Mac-1 and generation of leukotriene B(4) by human polymorphonuclear leukocytes Oral Oncol 40 2004 506
51. H.B. Lieberman DNA damage repair and response protein as targets for cancer therapy Curr Med Chem 15 2008 360
52. J. Moan, and S. Sommer Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells Cancer Res 45 1985 1608
53. B.W. Henderson, and V.H. Fingar Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor Cancer Res 47 1987 3110
54. D. Shweiki, A. Itin, D. Soffer, and E. Keshet Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature 359 1992 843
55. R. Eyssen-Hernandez, A. Ladoux, and C. Frelin Differential regulation of cardiac heme oxygenase-1 and vascular endothelial growth factor mRNA expressions by hemin, heavy metals, heat shock and anoxia FEBS Lett 382 1996 229
56. N. Solban, P.K. Selbo, A.K. Sinha, S.K. Chang, and T. Hassan Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer Cancer Res 66 2006 5633
57. F. Jiang, Z.G. Zhang, and M. Katakowski Angiogenesis induced by photodynamic therapy in normal rat brains Photochem Photobiol 79 2004 494
58. B. Laquente, F. Vinals, and J.R. Germa Metronomic chemotherapy: an antiangiogenic scheduling Clin Transl Oncol 9 2007 93
59. H. Hurwitz, L. Fehrenbacher, and W. Novotny Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2004 2335